Skip to main content

Table 2 Comparison between acute HF patients admitted with hsCRP below and above 25 mg/L

From: Is there a C-reactive protein value beyond which one should consider infection as the cause of acute heart failure?

Characteristics hsCRP< 25 mg/L (n = 347) hsCRP≥25 mg/L (n = 268) p-value
Male sex, n (%) 144 (41.5) 134 (50.0) 0.04
Age, mean (SD) 76 (12) 77 (12) 0.53
Atrial fibrillation, n (%) 159 (45.8) 121 (45.1) 0.88
Diabetes mellitus, n (%) 149 (42.9) 104 (38.8) 0.30
Coronary heart disease, n (%) 143 (41.2) 108 (40.3) 0.83
Admission NYHA IV (vs II/III) 207 (59.6) 164 (61.2) 0.87
Admission heart rate (bpm), mean (SD) 88 (24) 89 (23) 0.58
Admission systolic blood pressure (mmHg), mean (SD) 137 (29) 130 (29) 0.01
Left ventricular systolic dysfunction, n (%) 215 (62.0) 156 (58.2) 0.22
Haemoglobin (mmol/L), mean (SD) 7.4 (1.3) 7.1 (1.3) < 0.001
Leukocytes (cells/μL) 7918 (3172) 9645 (3972) < 0.001
Neutrophils (cells/μL) 5861 (2830) 7534 (3543) < 0.001
Monocyte-to-Lymphocyte Ratio, mean (SD) 0.53 (0.36) 0.67 (0.40) < 0.001
Glomerular filtration rate (mL/min/1.73m2) 48.0 (20.7) 45.4 (21.0) 0.13
Infectious condition at admission, n (%) 70 (20.2) 186 (69.4) < 0.001
BNP (pmol/L), median (IQR) 446.8 (252.2–797.0) 549.0 (304.4–848.8) 0.05
Acetylsalicylic acid, n (%) 167 (48.1) 126 (47.0) 0.69
Statin, n (%) 165 (47.6) 143 (53.4) 0.19
1-year death 130 (37.5) 102 (38.1) 0.88
  1. BNP B-type natriuretic peptide, hsCRP high sensitivity C-reactive protein, IQR interquartile range, NYHA New York Heart Association, SD standard deviation